GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Divi's Laboratories DIVISLAB.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

11,565.50

+12.06%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Divi's Laboratories

Its shares trade on NSE under the ticker DIVISLAB.NS. It has been listed since 25 June 1905. In the fiscal year to 31 March 2025, it reported revenue of ₹93.60bn and net income of ₹21.91bn. At that date it held total assets of ₹169.32bn and shareholders' equity of ₹149.69bn.

Divi's Laboratories Ltd. is a holding company, which engages in the manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. The company is headquartered in Hyderabad, Telangana. The Company’s products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl and Vigabatrin. The Company’s subsidiaries include Divi’s Laboratories USA, Inc., (Divi’s USA) and Divi’s Laboratories Europe AG (Divi’s Europe).

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Life Sciences Tools & Services
Listed since
25 Jun 1905
Employees
16,543

Leadership

Pay as last reported

  • Dr. Ramesh NimmagaddaNon-Executive Independent Chairman of the Board₹3.5m
  • Dr. Kiran DiviChief Executive Officer, Whole-Time Director, since 2020₹307.7m
  • Mr. L. Kishore BabuChief Financial Officer, since 2010₹35.4m
  • Mr. Venkatesa PasumarthyChief Financial Officer
  • Mr. Manoranjan JastiChief Information Officer
  • Mr. Meka Satish ChoudhuryCompliance Officer, Company Secretary₹4.2m
  • Dr. Murali DiviManaging Director, Executive Director, since 2020₹881.5m
  • Ms. Nilima DiviWhole-Time Director - (Commercial)₹307.0m
  • Shri. Nimmagadda RamanaExecutive Director, since 1994₹451.8m
  • Dr. Sureddy RaoWhole-Time Director - (Manufacturing), since 2024₹31.1m
  • Shri. Kosaraju ChowdaryNon-Executive Independent Director₹3.1m
  • Dr. Seru GanapatyNon-Executive Independent Director₹3.2m

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
77
Environment
88
Social
90
Governance
52
Direct emissions (scope 1)
363,246 t
Energy emissions (scope 2)
325,972 t
Women in the workforce
9.79228%
Carbon reduction policy
Yes
Human rights policy
Yes

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.